Iran vs North America: Immunization, measles second dose (% of children by the nationally)
Iran
99.0%
in 2024
North America
93.5%
in 2024
Iran rank
1st
North America rank
2nd
Immunization, measles second dose (% of children by the nationally) over time
- Iran
- North America
How they compare
Iran currently reports 99.0% against 93.5% in North America, a difference of 5.5%.
That makes Iran's figure about 1.1 times North America's.
Across all 25 years both countries report, Iran has been ahead every year.
Iran ranks 1st and North America ranks 2nd of 178 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran | North America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.6% | 79.2% | 17.4% | Iran |
| 2010s | 98.0% | 90.3% | 7.7% | Iran |
| 2020s | 98.4% | 93.7% | 4.7% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Iran or North America?
- Iran, at 99.0% against 93.5% in North America as of 2024.
- What is the difference in immunization, measles second dose between Iran and North America?
- 5.5%, with Iran ahead.
- How many years of comparable data are there for Iran and North America?
- 25 years are reported by both, from 2000 to 2024.
- How do Iran and North America rank globally for immunization, measles second dose?
- Iran ranks 1st and North America ranks 2nd of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.